Additionally, the collected data support the investigation of RANKL, OPG, and SOST as potential diagnostic markers for osteoporosis related to SM: these cytokines may serve as novel treatment targets in mastocytosis with bone implications [45]. This evidence concerns the gene TNFRSF11B and mastocytosis.